Intuitive Surgical Inc

AI Summary

Intuitive Surgical manufactures the da Vinci Surgical System, a robotic platform that enables surgeons to perform complex operations through small incisions, reducing patient recovery time [Intuitive.com]. The company also produces the Ion endoluminal system for minimally invasive lung biopsies and provides a full suite of instruments, training, and 24/7 technical support to hospitals [Intuitive.com]. Revenue comes from three streams: selling capital equipment (the robots), selling disposable instruments used during each procedure, and ongoing service contracts [Intuitive.com].

Intuitive Surgical is the dominant maker of robotic surgery systems—primarily the da Vinci platform—that help doctors perform minimally invasive procedures [Intuitive.com]. The stock has fallen 20% year-to-date despite strong underlying business momentum, with procedure volumes up 16% and the new da Vinci 5 system showing higher utilization than prior generations [Yahoo Finance]. The company reported $2.77 billion in Q1 revenue, beating analyst expectations, and continues to expand its installed base at 12% annually [Yahoo Finance].

Financially excellent with strong margins, negative net debt, and high returns on capital [Yahoo Finance].

Recent News

• Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

  Zacks· 2026-05-19

• Assessing Intuitive Surgical (ISRG) Valuation After The Recent Share Price Pullback

  Simply Wall St· 2026-05-18

• Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?

  Yahoo Finance· 2026-05-14

• Intuitive Surgical (ISRG) Is Among The Best Agentic AI Stocks To Buy Right Now

  Yahoo Finance· 2026-05-14

• Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

  Yahoo Finance· 2026-05-15

• Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.

  Yahoo Finance· 2026-05-14